Etravirine Tablet — FDA Drug Shortage

To Be Discontinued — Janssen Research and Development

The FDA lists a drug shortage record for Etravirine Tablet (tablet) from Janssen Research and Development with status To Be Discontinued. The shortage was first posted on 04/28/2026.

Shortage Details

Status
To Be Discontinued
Company
Janssen Research and Development
Package NDC
10147-0570-1
Dosage Form
Tablet
Presentation
Etravirine, Tablet, 100 mg (NDC 10147-0570-1)
Initial Posting
04/28/2026
Revised Date